December 11, 2023
Summarization of a recent webinar event Roche hosted featuring experts from the University of California-Davis and their health system’s approach to respiratory multiplex testing.
What are multiplex tests?
They are parts of syndromic testing that can include very large multi-pathogen panels or targeted panels with two or more pathogens.
Since the pandemic ended and demand for respiratory testing has greatly lessened, many labs have more diversity in platform options than before. This adds new complexity to evaluating the most efficient and effective way to approach respiratory disease testing. And now, more than ever before, there is a range of multiplex and panel tests available that can detect a variety of respiratory diseases.
Nam Tram, Ph.D., and Larissa May, M.D., both of the University of California-Davis, a Roche Diagnostics Center of Excellence, explain how their institution uses the following platforms in a test-to-treat model that includes multiplex testing when appropriate.